Pablo Pelegrín Selected Research

Pablo Pelegrín Research Topics

Disease

21	Inflammation (Inflammations) 11/2023 - 01/2008
10	Infections 08/2023 - 05/2004
6	Cryopyrin-Associated Periodic Syndromes 01/2023 - 08/2014
3	Fibrosis (Cirrhosis) 11/2022 - 01/2017
2	Rupture 12/2023 - 01/2021
2	Ischemia 11/2023 - 01/2023
2	Type 2 Diabetes Mellitus (MODY) 10/2023 - 11/2020
2	Sepsis (Septicemia) 01/2023 - 01/2022
2	Peritonitis 12/2021 - 09/2011
2	Atherosclerosis 11/2020 - 01/2013
2	Neoplasms (Cancer) 01/2020 - 01/2017
1	Brain Death (Brain Dead) 04/2024
1	End Stage Liver Disease 04/2024
1	Thrombosis (Thrombus) 11/2023
1	Obesity 10/2023
1	Cardiovascular Diseases (Cardiovascular Disease) 10/2023
1	Non-alcoholic Fatty Liver Disease 10/2023
1	COVID-19 08/2023
1	Hypoxia (Hypoxemia) 01/2023
1	Virus Diseases (Viral Diseases) 01/2023
1	Liver Cirrhosis (Hepatic Cirrhosis) 11/2022
1	Reperfusion Injury 11/2022
1	Status Epilepticus (Complex Partial Status Epilepticus) 01/2022
1	Central Nervous System Diseases (CNS Diseases) 01/2022
1	Hypertension (High Blood Pressure) 01/2021
1	Chronic Renal Insufficiency 01/2021
1	Kidney Diseases (Kidney Disease) 01/2021
1	Alzheimer Disease (Alzheimer's Disease) 11/2020
1	Necrosis 06/2020
1	Colorectal Neoplasms (Colorectal Cancer) 01/2020
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 11/2017
1	Colitis 11/2017
1	Melanoma (Melanoma, Malignant) 01/2017
1	Metabolic Diseases (Metabolic Disease) 01/2017
1	Familial Mediterranean Fever (Periodic Disease) 01/2017
1	Skin Diseases (Skin Disease) 01/2017
1	Chronic Obstructive Pulmonary Disease (COPD) 07/2016
1	Bacterial Infections (Bacterial Infection) 01/2016
1	Wounds and Injuries (Trauma) 06/2014

Drug/Important Bio-Agent (IBA)

20	InflammasomesIBA 10/2023 - 05/2015
7	Proteins (Proteins, Gene)FDA Link 08/2023 - 08/2014
5	Adenosine Triphosphate (ATP)IBA 01/2023 - 01/2012
5	CytokinesIBA 01/2023 - 09/2011
4	Purinergic P2X7 ReceptorsIBA 01/2022 - 07/2011
4	NucleotidesIBA 01/2022 - 01/2017
3	GasderminsIBA 12/2023 - 01/2020
3	InterleukinsIBA 11/2020 - 01/2016
2	N- (1,2,3,5,6,7- hexahydro- S- indacen- 4- ylcarbamoyl)- 4- (2- hydroxy- 2- propanyl)- 2- furansulfonamideIBA 01/2023 - 10/2022
2	Purinergic Receptors (Receptors, Purine)IBA 01/2023 - 01/2013
2	AntioxidantsIBA 04/2022 - 01/2021
2	Leucine (L-Leucine)FDA Link 01/2022 - 10/2017
2	Messenger RNA (mRNA)IBA 07/2016 - 01/2008
2	ProstaglandinsIBA 01/2016 - 07/2012
1	dicarboxydine (DCD)IBA 04/2024
1	defibrotideIBA 11/2023
1	Isoantigens (Alloantigen)IBA 11/2023
1	PolyphenolsIBA 10/2023
1	Biomarkers (Surrogate Marker)IBA 08/2023
1	Interleukin-18 (Interleukin 18)IBA 01/2023
1	ProcalcitoninIBA 01/2023
1	Interleukin-6 (Interleukin 6)IBA 01/2023
1	Interleukin-8 (Interleukin 8)IBA 01/2023
1	Carbamazepine (Tegretol)FDA LinkGeneric 01/2022
1	LipopolysaccharidesIBA 01/2022
1	Phenytoin (Dilantin)FDA LinkGeneric 01/2022
1	ConvulsantsIBA 01/2022
1	Lorazepam (Ativan)FDA LinkGeneric 01/2022
1	Kainic Acid (Kainate)IBA 01/2022
1	Midazolam (Versed)FDA LinkGeneric 01/2022
1	Minocycline (Cyclops)FDA LinkGeneric 01/2022
1	ITH15004IBA 01/2022
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2022
1	Antihypertensive Agents (Antihypertensives)IBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	Mitochondrial DNA (mtDNA)IBA 01/2021
1	Serine Proteases (Serine Protease)IBA 01/2020
1	AzoxymethaneIBA 01/2020
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2020
1	Granzymes (Granzyme)IBA 01/2020
1	Peptide Hydrolases (Proteases)FDA Link 01/2020
1	Dextrans (Dextran)FDA Link 01/2020
1	Purinergic P2X ReceptorsIBA 01/2019
1	Biocompatible Materials (Biomaterials)IBA 01/2019
1	acrylic acid (acrylate)IBA 11/2017
1	2,4-dinitrobenzenesulfonic acidIBA 11/2017
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2017
1	PyrinIBA 01/2017
1	Caspase 1 (ICE Protease)IBA 07/2016
1	Annexin A1IBA 03/2016
1	Interleukin-10 (Interleukin 10)IBA 01/2016
1	Prostaglandin D2IBA 01/2016
1	LigandsIBA 01/2016
1	Leukotriene B4IBA 01/2016
1	CXC ChemokinesIBA 01/2016
1	Dual OxidasesIBA 06/2014

Therapy/Procedure

3	Liver Transplantation 04/2024 - 11/2022
3	Therapeutics 01/2022 - 07/2012
1	Critical Care (Surgical Intensive Care) 01/2023
1	Drug Therapy (Chemotherapy) 01/2022
1	Oral Administration 11/2017